Breaking News

An unconventional approach to target pancreatic tumors; U.S. cancer drug prices rose as they fell elsewhere

 

Cancer Briefing

STAT+: Scientists test common bacteria as a weapon to target pancreatic tumors

By Angus Chen

Courtesy Claudia Gravekamp

Pancreatic cancer has proved one of the most deadly forms of the disease, and the most difficult to crack.

Read More

STAT+: Despite competition, U.S. cancer drug prices rose even as they fell in Germany and Switzerland

By Ed Silverman

Adobe

A new analysis finds that cancer drug prices fell in Germany and Switzerland, but rose in the same time frame in the U.S.

Read More

STAT+: Lawmakers and a Pelosi aide turn lobbyist to push for new health agency's independence

By Lev Facher

Rich Pedroncell/AP

Xavier Becerra is the focus of a frenzied, last-minute lobbying effort from top lawmakers and a key Nancy Pelosi aide on ARPA-H.

Read More

Tuesday, March 29, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments